Insider · CIK 0001816465

Blackwell Kimberly

Reports to the SEC for 3 companies · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001816465

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.8K sh	—	—	25,800
2026-06-11	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+74K sh	—	—	74,000
2025-06-13	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30.7K sh	—	—	30,700
2025-06-12	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2024-06-20	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2024-06-12	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.1K sh	—	—	22,100
2024-02-01	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	504,800
2024-02-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	250,000
2024-02-01	ZNTLZentalis Pharmaceuticals, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−20.7K sh	$11.69	−$241K	484,145
2023-11-13	ZNTLZentalis Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$10.29	+$51.4K	254,800
2023-06-27	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2023-06-14	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2023-02-01	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+245K sh	—	—	249,800
2023-02-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+355K sh	—	—	355,200
2022-06-15	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-06-09	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.9K sh	—	—	19,872
2022-05-16	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+427K sh	—	—	427,202
2022-05-16	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.71M sh	—	—	1,708,809
2022-01-03	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,000 sh	$83.74	−$83.7K	5,000
2022-01-03	ZNTLZentalis Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,000 sh	$47.80	+$47.8K	6,000
2022-01-03	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,000 sh	—	—	38,000
2021-12-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,000 sh	—	—	39,000
2021-12-01	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,000 sh	$81.84	−$81.8K	5,000
2021-12-01	ZNTLZentalis Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,000 sh	$47.80	+$47.8K	6,000
2021-11-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,000 sh	—	—	40,000
2021-11-01	ZNTLZentalis Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,000 sh	$47.80	+$47.8K	6,000
2021-11-01	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,000 sh	$80.46	−$80.5K	5,000
2021-10-25	ZNTLZentalis Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,000 sh	$47.80	+$47.8K	6,000
2021-10-25	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,000 sh	$77.59	−$77.6K	5,000
2021-10-25	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,000 sh	$47.80	−$47.8K	41,000
2021-06-23	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+47.1K sh	—	—	47,132
2021-06-17	IPSCCentury Therapeutics, Inc. · Option (right to buy)A Award	Director	AAward	+19.9K sh	—	—	19,872
2021-06-04	ZNTLZentalis Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+5,000 sh	—	—	5,000
2021-06-04	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+15K sh	—	—	15,000
2021-04-12	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,081 sh	—	—	7,081
2020-07-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+42K sh	—	—	42,000

Recent filings

Accepted (ET)
Jun 124
Blackwell Kimberly0001193125-26-269349
SEC(opens sec.gov)
Jun 124
Blackwell Kimberly0001816465-26-000002
SEC(opens sec.gov)
Jun 164
Blackwell Kimberly0000950170-25-086702
SEC(opens sec.gov)
Jun 164
Blackwell Kimberly0001062993-25-011788
SEC(opens sec.gov)
Jun 214
Blackwell Kimberly0001062993-24-012900
SEC(opens sec.gov)
Jun 134
Blackwell Kimberly0000950170-24-073059
SEC(opens sec.gov)
Feb 54
Blackwell Kimberly0001725160-24-000026
SEC(opens sec.gov)
Nov 134
Blackwell Kimberly0001725160-23-000200
SEC(opens sec.gov)
Jun 294
Blackwell Kimberly0001062993-23-014168
SEC(opens sec.gov)
Jun 154
Blackwell Kimberly0001209191-23-037348
SEC(opens sec.gov)
Feb 14
Blackwell Kimberly0001725160-23-000018
SEC(opens sec.gov)
Jun 164
Blackwell Kimberly0001209191-22-037421
SEC(opens sec.gov)
Jun 104
Blackwell Kimberly0001062993-22-014656
SEC(opens sec.gov)
May 204
Blackwell Kimberly0001725160-22-000100
SEC(opens sec.gov)
Jan 54
Blackwell Kimberly0001725160-22-000005
SEC(opens sec.gov)

Companies

Address

C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR

PHILADELPHIA, PA, 19104